Weiss Ratings Reaffirms “Sell (E+)” Rating for 908 Devices (NASDAQ:MASS)

908 Devices (NASDAQ:MASS)‘s stock had its “sell (e+)” rating reissued by research analysts at Weiss Ratings in a research report issued on Saturday,Weiss Ratings reports.

Separately, Stephens reissued an “overweight” rating and set a $6.00 price target on shares of 908 Devices in a research note on Wednesday, January 15th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, 908 Devices currently has a consensus rating of “Moderate Buy” and a consensus target price of $5.33.

908 Devices Stock Up 8.9 %

Shares of 908 Devices stock opened at $4.53 on Friday. The stock’s 50-day simple moving average is $2.91 and its 200-day simple moving average is $2.92. 908 Devices has a 52 week low of $1.81 and a 52 week high of $7.56. The company has a market capitalization of $160.04 million, a price-to-earnings ratio of -2.56 and a beta of 0.99.

Institutional Investors Weigh In On 908 Devices

Institutional investors and hedge funds have recently modified their holdings of the business. B. Riley Wealth Advisors Inc. bought a new stake in shares of 908 Devices during the 3rd quarter worth approximately $45,000. Two Sigma Advisers LP bought a new stake in shares of 908 Devices during the 4th quarter worth approximately $30,000. Townsquare Capital LLC bought a new stake in shares of 908 Devices during the 3rd quarter worth approximately $50,000. Prudential Financial Inc. bought a new stake in shares of 908 Devices during the 4th quarter worth approximately $34,000. Finally, Occudo Quantitative Strategies LP purchased a new position in 908 Devices during the 4th quarter worth $36,000. 88.06% of the stock is owned by institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.